[go: up one dir, main page]

AU2002358815A1 - Methods of diagnosing and treating diabetes and obesity - Google Patents

Methods of diagnosing and treating diabetes and obesity

Info

Publication number
AU2002358815A1
AU2002358815A1 AU2002358815A AU2002358815A AU2002358815A1 AU 2002358815 A1 AU2002358815 A1 AU 2002358815A1 AU 2002358815 A AU2002358815 A AU 2002358815A AU 2002358815 A AU2002358815 A AU 2002358815A AU 2002358815 A1 AU2002358815 A1 AU 2002358815A1
Authority
AU
Australia
Prior art keywords
obesity
diagnosing
methods
treating diabetes
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002358815A
Inventor
Daniel Bach Gonzalez
Bernhard Baumgartner
Hans Burghardt Coll
Horacio Moreno Manzano
Josep Oriola Ambros
Manuel Palacin Prieto
Sara Pich Comas
Francisca Rivera Fillet
Xavier Testar Ympert
Antonio Zorzano Olarte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitat de Barcelona UB
Original Assignee
Universitat de Barcelona UB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitat de Barcelona UB filed Critical Universitat de Barcelona UB
Publication of AU2002358815A1 publication Critical patent/AU2002358815A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002358815A 2002-11-28 2002-11-28 Methods of diagnosing and treating diabetes and obesity Abandoned AU2002358815A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2002/000566 WO2004048610A1 (en) 2002-11-28 2002-11-28 Methods of diagnosing and treating diabetes and obesity

Publications (1)

Publication Number Publication Date
AU2002358815A1 true AU2002358815A1 (en) 2004-06-18

Family

ID=32338282

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002358815A Abandoned AU2002358815A1 (en) 2002-11-28 2002-11-28 Methods of diagnosing and treating diabetes and obesity

Country Status (2)

Country Link
AU (1) AU2002358815A1 (en)
WO (1) WO2004048610A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3199299A (en) * 1998-03-23 1999-10-18 Musc Foundation For Research Development Methods for identifying a risk to ucp2 and ucp3 gene variant-related afflictionsand compositions thereof
GB0000992D0 (en) * 2000-01-18 2000-03-08 Astrazeneca Uk Ltd Methods
US6608038B2 (en) * 2000-03-15 2003-08-19 Novartis Ag Methods and compositions for treatment of diabetes and related conditions via gene therapy
GB0024510D0 (en) * 2000-10-06 2000-11-22 Astrazeneca Ab Methods
US20020177151A1 (en) * 2001-02-26 2002-11-28 Millennium Pharmaceuticals, Inc. Methods for the treatment of metabolic disorders, including obesity and diabetes

Also Published As

Publication number Publication date
WO2004048610A1 (en) 2004-06-10

Similar Documents

Publication Publication Date Title
AU2002322394A1 (en) Method for treating diabetes and obesity
AU2003219934A1 (en) Method of treatment or prevention of obesity
AU2003207717B9 (en) 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
IL218909A0 (en) Treatment of diabetes
AU2003287436A1 (en) Apparatus and methods for treatment of morbid obesity
AU2003243420A1 (en) 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
AU2003259925A1 (en) Well treatment apparatus and method
AU2003220194A1 (en) Heart valve fixation process and apparatus
AU2003251191A1 (en) Microorganisms for inhibiting obesity and diabetes mellitus
AU2003257702A1 (en) Optometric device and optometric method
AU2002258428A1 (en) Methods for the treatment of metabolic disorders, including obesity and diabetes
AU2003297460A1 (en) TREATMENT OF OBESITY AND ASSOCIATED CONDITIONS WITH TGF-Beta INHIBITORS
AU2003277259A1 (en) Immunoassay and method of use
IL165304A0 (en) Method of treating diabetes
AU2003268032A1 (en) Composition and methods for treatment and screening
AU2002312211A1 (en) Methods and reagents for diagnosis and treatment of insulin resistance and related conditions
AU6050000A (en) Improved method of treating type ii diabetes and obesity
WO2003102163A8 (en) Methods of diagnosing and treating diabetes and insulin resistance
AU2003243427A1 (en) Methods of diagnosing and treating diabetes and insulin resistance
EP1572085A3 (en) Methods and compositions for treating and diagnosing diabetes
EP1572085A4 (en) Methods and compositions for treating and diagnosing diabetes
EP1511850A4 (en) Methods of treating and diagnosing diabetes with cx3cr1 modulators
AU2003237483A1 (en) Methods of diagnosing and treating diabetes and insulin resistance
AU2003231279A1 (en) Prevention and treatment of type 2 diabetes
AU2003240556A1 (en) Methods of diagnosing and treating diabetes and insulin resistance

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase